Brain Imaging in Cerebral Venous Outflow Disturbance

NCT ID: NCT05820165

Last Updated: 2023-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cerebral venous outflow disturbance can lead to cerebral hemodynamic disturbances, altered cerebrospinal fluid dynamics, cerebral venous blood stasis, increased cerebral venous pressure and decreased cerebral perfusion, cerebral white matter sparing-like changes, and widening of retinal vessel diameter. These changes are associated with numerous neurological signs and symptoms. Therefore, understanding the brain structural and functional changes in patients with cerebral venous outflow disturbance is essential to provide specific imaging evaluation indicators and new diagnosis and treatment methods for patients with cerebral venous return disorders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cerebral venous outflow disturbance can lead to cerebral hemodynamic disturbances, altered cerebrospinal fluid dynamics, cerebral venous blood stasis, increased cerebral venous pressure and decreased cerebral perfusion, cerebral white matter sparing-like changes, and widening of retinal vessel diameter. These changes are associated with numerous neurological signs and symptoms. A number of central nervous system disorders such as transient global amnesia, transient monocular blindness, primary labor headaches, and even Parkinson's have been reported to be closely associated with internal jugular vein stenosis. Other common clinical manifestations include sleep disturbances, tinnitus, tinnitus, headache, visual impairment, optic papilledema, hearing loss, cognitive decline and neck discomfort and even autonomic dysfunction. The main objective of this study is to investigate the structural and functional network changes in patients with cerebral venous outflow disturbance using different brain imaging techniques, to clarify the correlation between symptoms of cerebral venous outflow disturbance and brain structure and function; to identify areas with corresponding structural and functional changes in patients with cerebral venous outflow disturbance and or comorbid symptoms, and to provide specific imaging assessment indicators and new diagnostic and treatment tools for patients with cerebral venous outflow disturbance and comorbid symptoms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abnormal Cerebral Venous Sinus Morphology Internal Jugular Vein Stenosis Image

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CVOD-WS

Cerebral Venous Outflow Disturbance with symptoms such as tinnitus cerebri,somnipathy ,anxiety ,depression and cognitive decline

high-resolution 3D-T1

Intervention Type RADIATION

Subjects undergo a high-resolution 3D-T1 imaging to obtain structural images

diffusion tensor imaging (DTI)

Intervention Type RADIATION

Subjects undergo a DTI imaging to obtain images of white matter lesions

resting-state functional magnetic resonance imaging (rs-fMRI)

Intervention Type RADIATION

Subjects undergo rs-fMRI to investigate the differences in intra-regional brain activity and inter-regional functional connectivity

arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)

Intervention Type RADIATION

Subjects undergo arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) to clarify the difference of cerebral blood flow (CBF) perfusion in certain regions

susceptibility-weighted images (SWIs)

Intervention Type RADIATION

Subjects undergo susceptibility-weighted images (SWIs) to segment the vein network

CVOD-WOS

Cerebral Venous Outflow Disturbance without symptoms such as tinnitus cerebri,somnipathy ,anxiety ,depression and cognitive decline

high-resolution 3D-T1

Intervention Type RADIATION

Subjects undergo a high-resolution 3D-T1 imaging to obtain structural images

diffusion tensor imaging (DTI)

Intervention Type RADIATION

Subjects undergo a DTI imaging to obtain images of white matter lesions

resting-state functional magnetic resonance imaging (rs-fMRI)

Intervention Type RADIATION

Subjects undergo rs-fMRI to investigate the differences in intra-regional brain activity and inter-regional functional connectivity

arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)

Intervention Type RADIATION

Subjects undergo arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) to clarify the difference of cerebral blood flow (CBF) perfusion in certain regions

susceptibility-weighted images (SWIs)

Intervention Type RADIATION

Subjects undergo susceptibility-weighted images (SWIs) to segment the vein network

HC

Healthy control

high-resolution 3D-T1

Intervention Type RADIATION

Subjects undergo a high-resolution 3D-T1 imaging to obtain structural images

diffusion tensor imaging (DTI)

Intervention Type RADIATION

Subjects undergo a DTI imaging to obtain images of white matter lesions

resting-state functional magnetic resonance imaging (rs-fMRI)

Intervention Type RADIATION

Subjects undergo rs-fMRI to investigate the differences in intra-regional brain activity and inter-regional functional connectivity

arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)

Intervention Type RADIATION

Subjects undergo arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) to clarify the difference of cerebral blood flow (CBF) perfusion in certain regions

susceptibility-weighted images (SWIs)

Intervention Type RADIATION

Subjects undergo susceptibility-weighted images (SWIs) to segment the vein network

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

high-resolution 3D-T1

Subjects undergo a high-resolution 3D-T1 imaging to obtain structural images

Intervention Type RADIATION

diffusion tensor imaging (DTI)

Subjects undergo a DTI imaging to obtain images of white matter lesions

Intervention Type RADIATION

resting-state functional magnetic resonance imaging (rs-fMRI)

Subjects undergo rs-fMRI to investigate the differences in intra-regional brain activity and inter-regional functional connectivity

Intervention Type RADIATION

arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)

Subjects undergo arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) to clarify the difference of cerebral blood flow (CBF) perfusion in certain regions

Intervention Type RADIATION

susceptibility-weighted images (SWIs)

Subjects undergo susceptibility-weighted images (SWIs) to segment the vein network

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cerebral venous outflow disturbance( moderate to severe stenosis in cerebral venous sinus or intracranial jugular veins ) is confirmed by two of magnetic resonance venography (MRV), computed tomography venography (CTV) or digital subtraction angiography (DSA)
* Accompanying symptoms such as tinnitus cerebri, cognitive decline, anxiety depression, sleep disorders, etc. for more than 6 months

Exclusion Criteria

* ear primary disease medicine related intracranial hypertension; Systemic disease of abnormal metabolism or inflammation; moderate to severe stenosis in intracranial, carotid or vertebral arteries; intracranial lesions.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Capital Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ji Xunming,MD,PhD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xunming Ji, MD.PhD

Role: PRINCIPAL_INVESTIGATOR

Xuanwu Hospital, Beijing

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xuanwu hospital;Capital Medical University

Beijin, XI Cheng District, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xunming Ji

Role: CONTACT

010-83199430

Lu Liu, MD

Role: CONTACT

13370186128

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xunming Ji

Role: primary

+86-10-83198952

References

Explore related publications, articles, or registry entries linked to this study.

Luan Y, Wang C, Jiao Y, Tang T, Zhang J, Teng GJ. Prefrontal-Temporal Pathway Mediates the Cross-Modal and Cognitive Reorganization in Sensorineural Hearing Loss With or Without Tinnitus: A Multimodal MRI Study. Front Neurosci. 2019 Mar 12;13:222. doi: 10.3389/fnins.2019.00222. eCollection 2019.

Reference Type BACKGROUND
PMID: 30930739 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COVD-BI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.